MEDNAX (MD) Misses Q3 EPS by 12c

MEDNAX (NYSE: MD) reported Q3 EPS of $0.32, $0.12 worse than the analyst estimate of $0.44. Revenue for the quarter came in at $507 million versus the consensus estimate of $508.47 million.

For earnings history and earnings-related data on MEDNAX (MD) click here.

You May Also Be Interested In

• Are we witnessing a fundamental or speculative rally in the S&P 500?
• Palo Alto Networks stock dips despite quarterly beat, raised profit outlook
• Morgan Stanley lifts MU and SNDK targets, sees 2-3 years of tight memory supply